{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:18:24Z","timestamp":1783358304325,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["PB-PG-0817-20013"],"award-info":[{"award-number":["PB-PG-0817-20013"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["ARC North Thames"],"award-info":[{"award-number":["ARC North Thames"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To understand the perspectives and experiences of patients and healthcare professionals regarding the trial design, recruitment and randomisation process to a novel cohort-embedded RCT design for Nephron Sparing Treatment (NEST) for small renal masses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were adult patients with a small renal mass (&lt;\u20094\u00a0cm) randomised to receive either percutaneous cryotherapy (CRO) or robot-assisted partial nephrectomy (PRN), and clinicians involved in a trial comparing the two treatments. Semi-structured interviews followed a phenomenological approach and were transcribed verbatim and analysed using thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Interviews were conducted with 37 patients and 10 clinicians. Wanting to \u2018give back\u2019 influenced participants\u2019 decisions to take part in the trial. Most patients expressed that they had a positive and informed experience of the trial. Patients who accepted randomisation to cryotherapy (experimental intervention) were influenced by information provided regarding a potentially shorter recovery timeframe, length of hospitalisation, and lower risk of complication. Those who were randomised to receive partial nephrectomy (standard of care intervention) stated that they felt less anxious receiving \u2018non-experimental\u2019 treatment and felt safer in the knowledge that the tumour was removed. Clinicians expressed that the trial presented an opportunity to work collegially in identifying the best treatment for patients presenting with SRMs, though highlighted that limited consultation time was a challenge to recruitment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings support the potential feasibility of a future multicentre trial comparing percutaneous cryoablation to robot-assisted partial nephrectomy in the treatment of small renal masses. The study\u2019s design, process and intervention were accepted by most, though not all, participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ISRCTN18156881<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-026-01833-7","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:15:53Z","timestamp":1778638553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nephron Sparing Treatment (NEST) for small renal masses: understanding patients\u2019 and clinicians\u2019 experiences of a cohort-embedded randomised control trial"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0528-8640","authenticated-orcid":false,"given":"Veronica","family":"Ranieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana B.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Santiapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Walkden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Patki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Barod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aitchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Wildgoose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurinchi","family":"Gurusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine G. B.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"18","key":"1833_CR1","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/jnci\/djj362","volume":"98","author":"JM Hollingsworth","year":"2006","unstructured":"Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331\u20134.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1833_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ucl.2016.12.001","volume":"44","author":"RM Turner 2nd","year":"2017","unstructured":"Turner RM 2nd, Morgan TM, Jacobs BL. Epidemiology of the small renal mass and the treatment disconnect phenomenon. Urol Clin North Am. 2017;44(2):147\u201354.","journal-title":"Urol Clin North Am"},{"issue":"5","key":"1833_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035938","volume":"10","author":"NS Vasudev","year":"2020","unstructured":"Vasudev NS, Wilson M, Stewart GD, Adeyoju A, Cartledge J, Kimuli M, et al. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open. 2020;10(5):e035938.","journal-title":"BMJ Open"},{"issue":"6","key":"1833_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2214\/AJR.10.6336","volume":"196","author":"O Stakhovskyi","year":"2011","unstructured":"Stakhovskyi O, Yap SA, Leveridge M, Lawrentschuk N, Jewett MA. Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results. AJR Am J Roentgenol. 2011;196(6):1267\u201373.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"1833_CR5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljunberg","year":"2015","unstructured":"Ljunberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913\u201324.","journal-title":"Eur Urol"},{"issue":"81","key":"1833_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21810","volume":"21","author":"N Soomro","year":"2017","unstructured":"Soomro N, Lecouturier J, Stocken DD, Shen J, Hynes AM, Ainsworth HF, et al. Surveillance versus ablation for incidentally diagnosed small renal tumours: the SURAB feasibility RCT. Health Technol Assess. 2017;21(81):1\u201368.","journal-title":"Health Technol Assess"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2466-14-71","volume":"14","author":"E Beekman","year":"2014","unstructured":"Beekman E, Mesters I, Hendriks EJ, Muris JW, Wesseling G, Evers SM, et al. Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial. BMC Pulm Med. 2014;14:71.","journal-title":"BMC Pulm Med"},{"issue":"11","key":"1833_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/0284186X.2016.1189094","volume":"55","author":"JP Burbach","year":"2016","unstructured":"Burbach JP, Kurk SA, Coebergh van den Braak RR, Dik VK, May AM, Meijer GA, et al. Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research. Acta Oncol. 2016;55(11):1273\u201380.","journal-title":"Acta Oncol"},{"key":"1833_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-1683(23)01438-6","author":"JB Neves","year":"2023","unstructured":"Neves JB, Warren H, Santiapillai J, Rode N, Cullen D, Pavlou M, et al. Nephron Sparing Treatment (NEST) for small renal masses: a feasibility cohort-embedded randomised controlled trial comparing percutaneous cryoablation and robot-assisted partial nephrectomy. Eur Urol. 2023. https:\/\/doi.org\/10.1016\/s2666-1683(23)01438-6.","journal-title":"Eur Urol"},{"key":"1833_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111469","volume":"174","author":"A Amstutz","year":"2024","unstructured":"Amstutz A, Schonenberger CM, Speich B, Griessbach A, Schwenke JM, Glasstetter J, et al. Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - a scoping review. J Clin Epidemiol. 2024;174:111469.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1833_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030965","volume":"9","author":"JB Neves","year":"2019","unstructured":"Neves JB, Cullen D, Grant L, Walkden M, Bandula S, Patki P, et al. Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses. BMJ Open. 2019;9(6):e030965.","journal-title":"BMJ Open"},{"key":"1833_CR12","volume-title":"NVivo [program]","author":"QSR International","year":"2018","unstructured":"QSR International. NVivo [program]. Melbourne, Australia: QSR International; 2018."},{"key":"1833_CR13","volume-title":"Narrative Methods for the Human Sciences","author":"CK Riessman","year":"2008","unstructured":"Riessman CK. Narrative Methods for the Human Sciences. London: Sage Publications; 2008."},{"issue":"3","key":"1833_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(3):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"1833_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-31","volume":"11","author":"SK McCann","year":"2010","unstructured":"McCann SK, Campbell MK, Entwistle VA. Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials. 2010;11:31.","journal-title":"Trials"},{"key":"1833_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cognition.2020.104244","volume":"200","author":"AN Hornsby","year":"2020","unstructured":"Hornsby AN, Love BC. How decisions and the desire for coherency shape subjective preferences over time. Cognition. 2020;200:104244.","journal-title":"Cognition"},{"issue":"5","key":"1833_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0277-9536(01)00197-6","volume":"55","author":"K Featherstone","year":"2002","unstructured":"Featherstone K, Donovan JL. \u201cWhy don\u2019t they just tell me straight, why allocate it?\u201d The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med. 2002;55(5):709\u201319.","journal-title":"Soc Sci Med"},{"issue":"4","key":"1833_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/17407745211009529","volume":"18","author":"HA Taylor","year":"2021","unstructured":"Taylor HA, Washington D, Wang NY, Patel HD, Ford DE, Kass NE, et al. Randomized comparison of two interventions to enhance understanding during the informed consent process for research. Clin Trials. 2021;18(4):466\u201376.","journal-title":"Clin Trials"},{"issue":"1","key":"1833_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1740774517746610","volume":"15","author":"AJ Vickers","year":"2018","unstructured":"Vickers AJ, Young-Afat DA, Ehdaie B, Kim SY. Just-in-time consent: the ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care. Clin Trials. 2018;15(1):3\u20138.","journal-title":"Clin Trials"},{"issue":"1","key":"1833_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1740774517746620","volume":"15","author":"SY Kim","year":"2018","unstructured":"Kim SY, Flory J, Relton C. Ethics and practice of trials within cohorts: an emerging pragmatic trial design. Clin Trials. 2018;15(1):9\u201316.","journal-title":"Clin Trials"},{"key":"1833_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jclinepi.2022.04.015","volume":"148","author":"ME Verweij","year":"2022","unstructured":"Verweij ME, Gal R, Burbach JPM, Young-Afat DA, van der Velden JM, van der Graaf R, et al. Most patients reported positively or neutrally of having served as controls in the trials within cohorts design. J Clin Epidemiol. 2022;148:39\u201347.","journal-title":"J Clin Epidemiol"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-026-01833-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-026-01833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-026-01833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:02:28Z","timestamp":1783357348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40814-026-01833-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1186\/s40814-026-01833-7","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Authority NHS and Health and Care Research Wales (HCRW), Research Ethics Committee reference 19\/EM.0004. All participants provided informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MGBT has received honoraria and advisory fees from MSD, Angiodynamics and Boston Scientific. No other authors report competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}